{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:46:47Z","timestamp":1792691207163,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:00:00Z","timestamp":1404691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:00:00Z","timestamp":1404691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep05587","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T09:08:29Z","timestamp":1404724109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model"],"prefix":"10.1038","volume":"4","author":[{"given":"Jia","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyue","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Lung","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Liong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yick Pang","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Chuen Chung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok Fai","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Tipoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,7]]},"reference":[{"key":"BFsrep05587_CR1","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","volume":"40","author":"JD Browning","year":"2004","unstructured":"Browning, J. D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 40, 1387\u20131395 (2004).","journal-title":"Hepatology."},{"key":"BFsrep05587_CR2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","volume":"10","author":"GA Michelotti","year":"2013","unstructured":"Michelotti, G. A., Machado, M. V. & Diehl, A. M. NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10, 656\u2013665 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFsrep05587_CR3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/apt.12046","volume":"36","author":"Y Yilmaz","year":"2012","unstructured":"Yilmaz, Y. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment. Pharmacol. Ther. 36, 815\u2013823 (2012).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFsrep05587_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1499-3872(13)60021-1","volume":"12","author":"J Xiao","year":"2013","unstructured":"Xiao, J., Guo, R., Fung, M. L., Liong, E. C. & Tipoe, G. L. Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. Hepatobiliary Pancreat. Dis. Int. 12, 125\u2013135 (2013).","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"BFsrep05587_CR5","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hep.23902","volume":"52","author":"P Vitaglione","year":"2010","unstructured":"Vitaglione, P. et al. Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology. 52, 1652\u20131661 (2010).","journal-title":"Hepatology."},{"key":"BFsrep05587_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00394-012-0301-0","volume":"52","author":"J Xiao","year":"2013","unstructured":"Xiao, J. et al. Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model. Eur. J. Nutr. 52, 179\u2013191 (2013).","journal-title":"Eur. J. Nutr."},{"key":"BFsrep05587_CR7","first-page":"642920","volume":"2013","author":"J Xiao","year":"2013","unstructured":"Xiao, J. et al. Garlic-Derived S-Allylmercaptocysteine Ameliorates Nonalcoholic Fatty Liver Disease in a Rat Model through Inhibition of Apoptosis and Enhancing Autophagy. Evid. Based Complement. Alternat. Med. 2013, 642920 (2013).","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"BFsrep05587_CR8","doi-asserted-by":"crossref","unstructured":"Xiao, J. et al. Epigallocatechin gallate attenuates fibrosis, oxidative stress and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1 and NF-kappa B pathways. Eur. J. Nutr. 10.1007\/s00394-013-0516-8 (2013).","DOI":"10.1007\/s00394-013-0516-8"},{"key":"BFsrep05587_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4254\/wjh.v5.i3.109","volume":"5","author":"F Cacciapuoti","year":"2013","unstructured":"Cacciapuoti, F., Scognamiglio, A., Palumbo, R., Forte, R. & Cacciapuoti, F. Silymarin in non alcoholic fatty liver disease. World J. Hepatol. 5, 109\u2013113 (2013).","journal-title":"World J. Hepatol."},{"key":"BFsrep05587_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fct.2012.10.026","volume":"52","author":"P Xin","year":"2013","unstructured":"Xin, P. et al. Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats. Food Chem. Toxicol. 52, 12\u201318 (2013).","journal-title":"Food Chem. Toxicol."},{"key":"BFsrep05587_CR11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10571-007-9181-x","volume":"28","author":"RC Chang","year":"2008","unstructured":"Chang, R. C. & So, K. F. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far? Cell. Mol. Neurobiol. 28, 643\u2013652 (2008).","journal-title":"Cell. Mol. Neurobiol."},{"key":"BFsrep05587_CR12","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.lfs.2004.11.009","volume":"76","author":"M Zhang","year":"2005","unstructured":"Zhang, M. et al. Effect of lycium barbarum polysaccharide on human hepatoma QGY7703 cells: inhibition of proliferation and induction of apoptosis. Life Sci. 76, 2115\u20132124 (2005).","journal-title":"Life Sci."},{"key":"BFsrep05587_CR13","doi-asserted-by":"crossref","unstructured":"Li, S. Y. et al. Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia\/reperfusion injury. PloS one 6 (2011).","DOI":"10.1371\/journal.pone.0016380"},{"key":"BFsrep05587_CR14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jep.2011.11.033","volume":"139","author":"J Xiao","year":"2012","unstructured":"Xiao, J. et al. Lycium barbarum polysaccharides protect mice liver from carbon tetrachloride-induced oxidative stress and necroinflammation. J. Ethnopharmacol. 139, 462\u2013470 (2012).","journal-title":"J. Ethnopharmacol."},{"key":"BFsrep05587_CR15","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1038\/nutd.2013.22","volume":"3","author":"J Xiao","year":"2013","unstructured":"Xiao, J. et al. Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury. Nutr. Diabetes. 3, e81 (2013).","journal-title":"Nutr. Diabetes."},{"key":"BFsrep05587_CR16","first-page":"1161","volume":"24","author":"GL Tipoe","year":"2009","unstructured":"Tipoe, G. L. et al. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). Histol. Histopathol. 24, 1161\u20131169 (2009).","journal-title":"Histol. Histopathol."},{"key":"BFsrep05587_CR17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41, 1313\u20131321 (2005).","journal-title":"Hepatology."},{"key":"BFsrep05587_CR18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cmet.2009.03.013","volume":"9","author":"KK Cheng","year":"2009","unstructured":"Cheng, K. K. et al. APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab. 9, 417\u2013427 (2009).","journal-title":"Cell Metab."},{"key":"BFsrep05587_CR19","doi-asserted-by":"crossref","first-page":"E849","DOI":"10.1152\/ajpendo.90996.2008","volume":"297","author":"OP McGuinness","year":"2009","unstructured":"McGuinness, O. P., Ayala, J. E., Laughlin, M. R. & Wasserman, D. H. NIH experiment in centralized mouse phenotyping: the Vanderbilt experience and recommendations for evaluating glucose homeostasis in the mouse. Am. J. Physiol. Endocrinol. Metab. 297, E849\u2013E855 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFsrep05587_CR20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3945\/ajcn.111.014225","volume":"94","author":"I Krog-Mikkelsen","year":"2011","unstructured":"Krog-Mikkelsen, I. et al. The effects of L-arabinose on intestinal sucrase activity: dose-response studies in vitro and in humans. Am. J. Clin. Nutr. 94, 472\u2013478 (2011).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFsrep05587_CR21","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/jn\/126.9.2098","volume":"126","author":"KR Martin","year":"1996","unstructured":"Martin, K. R., Failla, M. L. & Smith, J. C., Jr Beta-carotene and lutein protect HepG2 human liver cells against oxidant-induced damage. J. Nutr. 126, 2098\u20132106 (1996).","journal-title":"J. Nutr."},{"key":"BFsrep05587_CR22","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1016\/j.molimm.2007.03.016","volume":"44","author":"J Xiao","year":"2007","unstructured":"Xiao, J. et al. Tumor necrosis factor-alpha gene from mandarin fish, Siniperca chuatsi: molecular cloning, cytotoxicity analysis and expression profile. Mol. Immunol. 44, 3615\u20133622 (2007).","journal-title":"Mol. Immunol."},{"key":"BFsrep05587_CR23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611\u2013622 (2009).","journal-title":"Clin. Chem."},{"key":"BFsrep05587_CR24","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0002-9440(10)65501-0","volume":"155","author":"D Cassiman","year":"1999","unstructured":"Cassiman, D. et al. Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am. J. Pathol. 155, 1831\u20131839 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFsrep05587_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2036.2005.02601.x","volume":"22 Suppl 2","author":"E Albano","year":"2005","unstructured":"Albano, E., Mottaran, E., Occhino, G., Reale, E. & Vidali, M. Review article: role of oxidative stress in the progression of non-alcoholic steatosis. Aliment. Pharmacol. Ther. 22 Suppl 2, 71\u201373 (2005).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFsrep05587_CR26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.intimp.2013.08.019","volume":"17","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1\/PI3K\/Akt pathway. Int. Immunopharmacol. 17, 714\u2013720 (2013).","journal-title":"Int. Immunopharmacol."},{"key":"BFsrep05587_CR27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cld.2012.05.003","volume":"16","author":"SE Mahady","year":"2012","unstructured":"Mahady, S. E. & George, J. Management of nonalcoholic steatohepatitis: an evidence-based approach. Clin. Liver Dis. 16, 631\u2013645 (2012).","journal-title":"Clin. Liver Dis."},{"key":"BFsrep05587_CR28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"9","author":"SA Polyzos","year":"2009","unstructured":"Polyzos, S. A., Kountouras, J. & Zavos, C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr. Mol. Med. 9, 299\u2013314 (2009).","journal-title":"Curr. Mol. Med."},{"key":"BFsrep05587_CR29","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jc.2006-0587","volume":"91","author":"KM Utzschneider","year":"2006","unstructured":"Utzschneider, K. M. & Kahn, S. E. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 91, 4753\u20134761 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFsrep05587_CR30","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2337\/db06-0391","volume":"55","author":"B Draznin","year":"2006","unstructured":"Draznin, B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: the two sides of a coin. Diabetes 55, 2392\u20132397 (2006).","journal-title":"Diabetes"},{"key":"BFsrep05587_CR31","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1210\/en.2006-0932","volume":"148","author":"TP Ciaraldi","year":"2007","unstructured":"Ciaraldi, T. P., Nikoulina, S. E., Bandukwala, R. A., Carter, L. & Henry, R. R. Role of glycogen synthase kinase-3 alpha in insulin action in cultured human skeletal muscle cells. Endocrinology 148, 4393\u20134399 (2007).","journal-title":"Endocrinology"},{"key":"BFsrep05587_CR32","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.3390\/molecules16032542","volume":"16","author":"D Cheng","year":"2011","unstructured":"Cheng, D. & Kong, H. The effect of Lycium barbarum polysaccharide on alcohol-induced oxidative stress in rats. Molecules. 16, 2542\u20132550 (2011).","journal-title":"Molecules."},{"key":"BFsrep05587_CR33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.foodchem.2008.03.064","volume":"113","author":"M Ming","year":"2009","unstructured":"Ming, M., Guanhua, L., Zhanhai, Y., Guang, C. & Xuan, Z. Effect of the Lycium barbarum polysaccharides administration on blood lipid metabolism and oxidative stress of mice fed high-fat diet in vivo. Food Chem. 113, 872\u2013877 (2009).","journal-title":"Food Chem."},{"key":"BFsrep05587_CR34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1542-3565(04)00616-0","volume":"3","author":"AE Feldstein","year":"2005","unstructured":"Feldstein, A. E. et al. Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 3, 384\u2013389 (2005).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFsrep05587_CR35","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/j.gastro.2007.01.033","volume":"132","author":"M Adachi","year":"2007","unstructured":"Adachi, M. et al. The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. Gastroenterology. 132, 1434\u20131446 (2007).","journal-title":"Gastroenterology."},{"key":"BFsrep05587_CR36","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1079\/BJN2001340","volume":"86 Suppl 1","author":"R van den Berg","year":"2001","unstructured":"van den Berg, R., Haenen, G. R., van den Berg, H. & Bast, A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br. J. Nutr. 86 Suppl 1, S121\u2013127 (2001).","journal-title":"Br. J. Nutr."},{"key":"BFsrep05587_CR37","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2174\/156800910791859425","volume":"10","author":"H Wang","year":"2010","unstructured":"Wang, H. & Cho, C. H. Effect of NF-kappaB signaling on apoptosis in chronic inflammation-associated carcinogenesis. Curr. Cancer Drug Targets. 10, 593\u2013599 (2010).","journal-title":"Curr. Cancer Drug Targets."},{"key":"BFsrep05587_CR38","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/10715762.2013.837577","volume":"47","author":"Y Sumida","year":"2013","unstructured":"Sumida, Y., Niki, E., Naito, Y. & Yoshikawa, T. Involvement of free radicals and oxidative stress in NAFLD\/NASH. Free Radic. Res. 47, 869\u2013880 (2013).","journal-title":"Free Radic. Res."},{"key":"BFsrep05587_CR39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.fct.2013.08.036","volume":"63","author":"L Li","year":"2014","unstructured":"Li, L. et al. Resveratrol modulates autophagy and NF-kappaB activity in a murine model for treating non-alcoholic fatty liver disease. Food Chem. Toxicol. 63, 166\u2013173 (2014).","journal-title":"Food Chem. Toxicol."},{"key":"BFsrep05587_CR40","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2009.05.023","volume":"137","author":"J Moscat","year":"2009","unstructured":"Moscat, J. & Diaz-Meco, M. T. p62 at the crossroads of autophagy, apoptosis and cancer. Cell. 137, 1001\u20131004 (2009).","journal-title":"Cell."},{"key":"BFsrep05587_CR41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.carbpol.2006.09.021","volume":"69","author":"XL Li","year":"2007","unstructured":"Li, X. L., Zhou, A. G. & Li, X. M. Inhibition of Lycium barbarum polysaccharides and Ganoderma lucidum polysaccharides against oxidative injury induced by \u03b3-irradiation in rat liver mitochondria. Carb. Pol. 69, 172\u2013178 (2007).","journal-title":"Carb. Pol."},{"key":"BFsrep05587_CR42","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.foodchem.2009.03.015","volume":"116","author":"CC Wang","year":"2009","unstructured":"Wang, C. C., Chang, S. C. & Chen, B. H. Chromatographic determination of polysaccharides in Lycium barbarum Linnaeus. Food Chem. 116, 595\u2013603 (2009).","journal-title":"Food Chem."},{"key":"BFsrep05587_CR43","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jpba.2008.04.001","volume":"47","author":"BS Inbaraj","year":"2008","unstructured":"Inbaraj, B. S. et al. Determination of carotenoids and their esters in fruits of Lycium barbarum Linnaeus by HPLC-DAD-APCI-MS. J. Pharm. Biomed. Anal. 47, 812\u2013818 (2008).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"BFsrep05587_CR44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11130-005-9550-5","volume":"60","author":"Y Peng","year":"2005","unstructured":"Peng, Y. et al. Quantification of zeaxanthin dipalmitate and total carotenoids in Lycium fruits (Fructus Lycii). Plant Foods Hum. Nutr. 60, 161\u2013164 (2005).","journal-title":"Plant Foods Hum. Nutr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep05587","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep05587.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep05587.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T08:10:44Z","timestamp":1672992644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep05587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep05587"],"URL":"https:\/\/doi.org\/10.1038\/srep05587","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,7]]},"assertion":[{"value":"29 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5587"}}